November 7, 2016 / 10:22 PM / a year ago

BRIEF-Bioscrip reports third quarter 2016 financial results

Nov 7 (Reuters) - Bioscrip Inc

* Bioscrip Inc- preliminary full year 2017 guidance is revenues in range of $940 million to $980 million

* Bioscrip Inc- preliminary full year 2017 guidance is adjusted ebitda in range of $50 million to $60 million

* Bioscrip Inc- updated full year 2016 guidance is revenues in range of $928 million to $934 million and adjusted ebitda in range of $27 million to $29 million.

* Fy2016 revenue view $940.9 million -- Thomson Reuters I/B/E/S

* Fy2017 revenue view $1.00 billion -- Thomson Reuters I/B/E/S

* Bioscrip reports third quarter 2016 financial results

* Q3 revenue $224.5 million versus i/b/e/s view $223.3 million

* Q3 loss per share $0.12

* Sees fy 2017 revenue $940 million to $980 million

* Q3 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below